Skip to main content
CTRE
NYSE Real Estate & Construction

CareTrust REIT Details Over $637M in Acquisitions and Active ATM Program Utilization

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: REIT Stocks · Real Estate
Sentiment info
Positive
Importance info
8
Price
$38.99
Mkt Cap
$8.818B
52W Low
$27.72
52W High
$41.72
52W Position info
41% above low
Off High info
6.5% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

CTRE sits 41% above its 52-week low of $27.72.

Summary

CareTrust REIT reported strong Q1 2026 financial results and detailed over $637 million in recent acquisitions and investments, alongside active utilization of its At-The-Market equity offering program, which generated $129.5 million in proceeds and has $363.6 million in unsettled forward contracts.


Key Events · M&A and Partnerships · CTRE

  • Significant Capital Deployment in Acquisitions

    The company detailed over $637 million in subsequent acquisitions and investments, including senior housing communities and skilled nursing facilities in the U.S. and U.K., demonstrating aggressive expansion.

  • Active At-The-Market (ATM) Program Utilization

    CareTrust REIT reported selling 3.5 million shares for $129.5 million in gross proceeds during Q1 2026 and has 9.5 million shares, representing $363.6 million, remaining unsettled under forward contracts from its $1.0 billion ATM program.

  • Strong Q1 Financial Performance

    Net income attributable to CareTrust REIT, Inc. increased to $80.2 million for Q1 2026, with basic and diluted EPS at $0.36. Rental income grew by 59% compared to the prior year period.

  • CEO's 10b5-1 Plan Terminated

    President and CEO David Sedgwick terminated a Rule 10b5-1 trading arrangement to sell up to 144,492 shares, removing a potential selling overhang.


Analysis · CTRE · Real Estate & Construction

This 10-Q provides comprehensive details on CareTrust REIT's robust growth strategy and its financing. The company reported strong Q1 2026 financial results, with significant increases in rental income and net income. Crucially, the filing details over $637 million in subsequent acquisitions and investments, demonstrating aggressive expansion in the healthcare real estate sector. This substantial capital deployment is being funded in part by the active utilization of its At-The-Market equity program, which has already generated $129.5 million in proceeds and has $363.6 million in unsettled forward contracts, indicating a proactive approach to capital management. The termination of the CEO's 10b5-1 selling plan also removes a minor potential overhang. Investors should view this filing as confirmation of the company's strong operational performance and its continued execution on growth initiatives, supported by effective financing strategies.

How filings like this one have moved

In the 30 days to Oct 3, 2026, 36.7% of the 1075 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.60%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CTRE was trading at $38.99 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $8.8B. The 52-week trading range was $27.72 to $41.72. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CTRE - Latest Insights

CTRE
Oct 02, 2026, 6:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $36.29
Real-time Price: $36.45 info
Change: +$0.160 (+0.44%) info
Market Cap: $8.577B info
CTRE
Oct 02, 2026, 4:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $36.70
Real-time Price: $36.45 info
Change: -$0.250 (-0.68%) info
Market Cap: $8.577B info
CTRE
Sep 15, 2026, 6:30 AM EDT
Source: BusinessWire
Importance Score:
9
Price at Filing: $38.11
Real-time Price: $36.45 info
Change: -$1.66 (-4%) info
Market Cap: $8.577B info
CTRE
Aug 06, 2026, 4:20 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $41.13
Real-time Price: $36.45 info
Change: -$4.68 (-11%) info
Market Cap: $8.577B info
CTRE
Aug 06, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $41.13
Real-time Price: $36.45 info
Change: -$4.68 (-11%) info
Market Cap: $8.577B info